This web site is part of the Business Intelligence Division of Informa PLC
This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.
Ionis Pharmaceuticals, Inc.
Drug Names(s): ISIS 388626
Description: ISIS 388626 is an antisense drug that inhibits the production of sodium dependent glucose co-transporter type 2 (SGLT2). Because SGLT2 is responsible for glucose re-absorption in the kidney, blocking that action promotes glucose excretion and lowers blood sugar.
Additional information available to subscribers only: